Intravitreal delivery of ciprofloxacin

被引:10
作者
Hainsworth, DP [1 ]
Conklin, JD [1 ]
Bierly, JR [1 ]
Ax, D [1 ]
Ashton, P [1 ]
机构
[1] DUKE EYE CTR,DURHAM,NC
关键词
D O I
10.1089/jop.1996.12.183
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
The objective of this work was to evaluate various methods of sustained delivery to acheive therapeutic intravitreal levels of ciprofloxacin as a potential therapy for endophthalmitis. Two types of intravitreal bioerodible sustained release devices of ciprofloxacin were evaluated in vitro. The most promising device was evaluated in rabbits and results compared with subconjunctival injections of a ciprofloxacin suspension. Subconjunctival injections failed to deliver therapeutic concentrations of ciprofloxacin into either the aqueous or vitreous. In vivo evaluation of the intravitreal device consistently delivered ciprofloxacin at levels above 1 ug/ml for up to four weeks. No retinal toxicity was noted by clinical examination or by electroretinogram. Intravitreal implantation of bioerodible ciprofloxacin devices can maintain vitreous concentrations above 1 ug/ml, more than the MIC90 of most organisms associated with endophalmitis. Implantation of these devices appears to be well tolerated and may represent a viable treatment for this disease. Further studies in endophthalmitis models are needed to evaluate device efficacy.
引用
收藏
页码:183 / 191
页数:9
相关论文
共 22 条
[1]   INTRAOCULAR CEFTAZIDIME AS AN ALTERNATIVE TO THE AMINOGLYCOSIDES IN THE TREATMENT OF ENDOPHTHALMITIS [J].
AABERG, TM ;
FLYNN, HW ;
MURRAY, TG .
ARCHIVES OF OPHTHALMOLOGY, 1994, 112 (01) :18-19
[2]  
BARZA M, 1983, INVEST OPHTH VIS SCI, V24, P1602
[3]   CIPROFLOXACIN CONCENTRATION IN THE RABBIT AQUEOUS-HUMOR AND VITREOUS FOLLOWING INTRAVENOUS AND SUB-CONJUNCTIVAL ADMINISTRATION [J].
BEHRENSBAUMANN, W ;
MARTELL, J .
INFECTION, 1988, 16 (01) :54-57
[4]   AMINOGLYCOSIDE TOXICITY IN THE TREATMENT OF ENDOPHTHALMITIS [J].
CAMPOCHIARO, PA ;
LIM, JI ;
BLOOME, MA ;
CONWAY, BP ;
FLYNN, H ;
MURRAY, TG ;
GRAND, MG ;
IBANEZ, HE ;
MEREDITH, TA ;
MEYERS, S ;
PACKO, KH ;
PHEASANT, T ;
RICHMOND, PP ;
RIDLEY, ME ;
WEITER, JJ ;
WILKINSON, CP .
ARCHIVES OF OPHTHALMOLOGY, 1994, 112 (01) :48-53
[5]  
DOFT BH, 1991, ARCH OPHTHALMOL-CHIC, V109, P188
[6]   EMPIRIC TREATMENT OF ENDOPHTHALMITIS - ARE AMINOGLYCOSIDES NECESSARY [J].
DONAHUE, SP ;
KOWALSKI, RP ;
ELLER, AW ;
DEVARO, JM ;
JEWART, BH .
ARCHIVES OF OPHTHALMOLOGY, 1994, 112 (01) :45-47
[7]  
DONNENFELD ED, 1994, OPHTHALMOLOGY, V101, P902
[8]  
ELBABA FZ, 1992, OPHTHALMOLOGY, V99, P483
[9]  
FORSTER RK, 1980, OPHTHALMOLOGY, V87, P313
[10]  
HIZUCHI T, 1963, J PHARM SCI, V52, P1145